Utility of the Caprini risk assessment model in guiding venous thromboembolism prophylaxis after abdominoplasty.
Abstract
[INTRODUCTION] Abdominoplasty carries a significant risk of venous thromboembolism (VTE). Two main strategies have been described for prophylaxis: systematic administration of low molecular weight heparin (LMWH) and risk-stratified management using the Caprini score. This study aimed to assess thromboembolic risk in abdominoplasty patients and compare the cost-effectiveness of a Caprini-based strategy with routine prophylaxis.
[METHODS] A retrospective review was performed on 219 patients who underwent abdominoplasty at a university plastic surgery unit where systematic LMWH prophylaxis was standard. Demographic data, Caprini score components, complications, and costs were analyzed, and a cost-effectiveness comparison between systematic LMWH and a Caprini-based approach was performed.
[RESULTS] The mean Caprini score was 3.3 ± 1.1 (range 1-10). All patients received LMWH for a mean of 14.9 ± 1.5 days. One patient (0.45 %) developed pulmonary embolism, and 13 (5.9 %) developed hematomas. Cost analysis indicated that a risk-stratified approach could reduce LMWH expenditure by 44.5 %.
[CONCLUSIONS] Applying the Caprini score for VTE prophylaxis in abdominoplasty may reduce unnecessary anticoagulation and associated complications, while generating substantial cost savings for centers that do not currently use this model.
[METHODS] A retrospective review was performed on 219 patients who underwent abdominoplasty at a university plastic surgery unit where systematic LMWH prophylaxis was standard. Demographic data, Caprini score components, complications, and costs were analyzed, and a cost-effectiveness comparison between systematic LMWH and a Caprini-based approach was performed.
[RESULTS] The mean Caprini score was 3.3 ± 1.1 (range 1-10). All patients received LMWH for a mean of 14.9 ± 1.5 days. One patient (0.45 %) developed pulmonary embolism, and 13 (5.9 %) developed hematomas. Cost analysis indicated that a risk-stratified approach could reduce LMWH expenditure by 44.5 %.
[CONCLUSIONS] Applying the Caprini score for VTE prophylaxis in abdominoplasty may reduce unnecessary anticoagulation and associated complications, while generating substantial cost savings for centers that do not currently use this model.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | abdominoplasty
|
복부성형술 | dict | 5 | |
| 해부 | pulmonary
|
scispacy | 1 | ||
| 약물 | heparin
|
C0019134
heparin
|
scispacy | 1 | |
| 약물 | LMWH
→ low molecular weight heparin
|
C0019139
Heparin, Low-Molecular-Weight
|
scispacy | 1 | |
| 약물 | [INTRODUCTION] Abdominoplasty
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | venous thromboembolism
|
C1861172
Venous Thromboembolism
|
scispacy | 1 | |
| 질환 | VTE
→ venous thromboembolism
|
C1861172
Venous Thromboembolism
|
scispacy | 1 | |
| 질환 | thromboembolic
|
C0333214
thromboembolic
|
scispacy | 1 | |
| 질환 | pulmonary embolism
|
C0034065
Pulmonary Embolism
|
scispacy | 1 | |
| 질환 | hematomas
|
C0018944
Hematoma
|
scispacy | 1 | |
| 질환 | abdominoplasty patients
|
scispacy | 1 | ||
| 기타 | venous
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Case report of a rare soft tissue tuberculosis in a patient undergoing lipoabdominoplasty.
- What is the potential role of the nonopioid suzetrigine in pain management?
- Ex Vivo and In Vivo Histological Evaluation of a 3-μm Wavelength, 40-μm Spot Size Fractional Laser System for Dermatology.
- Correspondence on "Lymphatic pathway remodeling in the supraumbilical region after abdominoplasty: A prospective cohort study".
- Sculpting Success-The TULUANHA: Modified TULUA Lipo-Abdominoplasty in Post-Bariatric Body Contouring.